EWSB Bancorp, Inc. /MD/ — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that EWSB Bancorp, Inc. /MD/ filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($4.18M) | Mar 25, 2026 |
| FY2025 | Dec 31, 2024 | ($1.70M) | Mar 25, 2026 |
| FY2024 | Dec 31, 2023 | ($935.2K) | Mar 24, 2025 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.67M) | Mar 25, 2026 |
| FY2025 | Dec 31, 2024 | ($2.22M) | Mar 25, 2026 |
| FY2024 | Dec 31, 2023 | ($1.48M) | Mar 24, 2025 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $104.9K | Mar 25, 2026 |
| FY2025 | Dec 31, 2024 | $105.9K | Mar 25, 2026 |
| FY2024 | Dec 31, 2023 | $30.4K | Mar 24, 2025 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $270.97M | Mar 25, 2026 |
| FY2025 | Dec 31, 2024 | $273.31M | Mar 25, 2026 |
| FY2024 | Dec 31, 2023 | $262.57M | Mar 24, 2025 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $257.75M | Mar 25, 2026 |
| FY2025 | Dec 31, 2024 | $257.68M | Mar 25, 2026 |
| FY2024 | Dec 31, 2023 | $251.03M | Mar 24, 2025 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.22M | Mar 25, 2026 |
| FY2025 | Dec 31, 2024 | $15.63M | Mar 25, 2026 |
| FY2025 | Dec 31, 2023 | $11.54M | Mar 25, 2026 |
| FY2024 | Dec 31, 2022 | $10.92M | Mar 24, 2025 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.32M | Mar 25, 2026 |
| FY2025 | Dec 31, 2024 | $17.50M | Mar 25, 2026 |
| FY2024 | Dec 31, 2023 | $19.20M | Mar 24, 2025 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.27M | Mar 25, 2026 |
| FY2025 | Dec 31, 2024 | $1.19M | Mar 25, 2026 |
| FY2024 | Dec 31, 2023 | $1.61M | Mar 24, 2025 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $38.37M | Mar 25, 2026 |
| FY2025 | Dec 31, 2024 | $24.20M | Mar 25, 2026 |
| FY2024 | Dec 31, 2023 | $19.03M | Mar 24, 2025 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (5) | Mar 25, 2026 |
| FY2025 | Dec 31, 2024 | (8) | Mar 25, 2026 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (5) | Mar 25, 2026 |
| FY2025 | Dec 31, 2024 | (8) | Mar 25, 2026 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 752,538 | Mar 25, 2026 |
| FY2025 | Dec 31, 2024 | 752,538 | Mar 25, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 24, 2025 |